Medline backers cash out in $3.1 billion share sale priced at $41
Selling shareholders priced a 75 million-share secondary offering of Medline Inc. at $41 a share, totaling about $3.1 billion. Medline will not sell stock or receive proceeds. Sellers include affiliates of Blackstone, Carlyle, Hellman & Friedman, and ADIA. The deal is expected to close March 10.